Antibody Drug Conjugates Market Analysis, Size, and Share by 2031
Antibody Drug Conjugates Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cleavable Linker and Non-Cleavable Linker), Application (Blood Cancer, Brain Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, and Others), Target (HER2, CD22, CD30, and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and Geography
- Status : Published
- Report Code : TIPRE00003494
- Category : Life Sciences
- No. of Pages : 293
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Application, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 21.3% during 2023–2031.
North America dominated the market in 2023.
Strategic investments by key players and an increase in the availability of approved products are among the significant factors fueling the market growth.
Expanding clinical trial pipeline is expected to emerge as a prime trend in the market in the coming years.
ADC Therapeutics SA, Pfizer Inc, F. Hoffmann-La Roche Ltd, Daiichi Sankyo Co Ltd, GSK Plc, Gilead Sciences Inc, AstraZeneca Plc, Astellas Pharma Inc, RemeGen Co Ltd, Takeda Pharmaceutical Co Ltd, Merck KGaA, Johnson & Johnson, Bristol-Myers Squibb Co, BioNTech SE, and AbbVie Inc are among the key players in the market.
The antibody drug conjugates market value is expected to reach US$ 38,077.45 million by 2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Antibody Drug Conjugates Market Landscape
4.1 PEST Analysis
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
4.2.2 List of Approved Products
4.2.3 Pipeline Analysis
4.2.4 Regulatory Guidelines
5. Antibody Drug Conjugates Market – Key Market Dynamics
5.1 Antibody Drug Conjugates Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Strategic Investments by Key Players
5.2.2 Increase in Availability of Approved Products
5.3 Market Restraints
5.3.1 Manufacturing Challenges
5.4 Market Opportunities
5.4.1 Expansion into New Indications
5.5 Future Trends
5.5.1 Expanding Clinical Trial Pipeline
5.6 Impact of Drivers and Restraints:
6. Antibody Drug Conjugates Market – Global Market Analysis
6.1 Antibody Drug Conjugates Market Revenue (US$ Million), 2021–2031
6.2 Overview
6.3 Antibody Drug Conjugates Market Forecast Analysis
7. Antibody Drug Conjugates Market Analysis – by Technology
7.1 Cleavable Linker
7.1.1 Overview
7.1.2 Cleavable Linker: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Non-cleavable Linker
7.2.1 Overview
7.2.2 Non-cleavable Linker: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8. Antibody Drug Conjugates Market Analysis – by Application
8.1 Blood Cancer
8.1.1 Overview
8.1.2 Blood Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Brain Cancer
8.2.1 Overview
8.2.2 Brain Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Ovarian Cancer
8.4.1 Overview
8.4.2 Ovarian Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Lung Cancer
8.5.1 Overview
8.5.2 Lung Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
9. Antibody Drug Conjugates Market Analysis – by Target
9.1 HER2
9.1.1 Overview
9.1.2 HER2: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
9.2 CD22
9.2.1 Overview
9.2.2 CD22: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
9.3 CD30
9.3.1 Overview
9.3.2 CD30: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
10. Antibody Drug Conjugates Market Analysis – by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Overview
10.1.2 Retail Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11. Antibody Drug Conjugates Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Antibody Drug Conjugates Market Overview
11.2.2 North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3 North America: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.3.1 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Technology
11.2.4 North America: Antibody Drug Conjugates Market Breakdown, by Application
11.2.4.1 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Application
11.2.5 North America: Antibody Drug Conjugates Market Breakdown, by Target
11.2.5.1 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Target
11.2.6 North America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.6.1 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.7 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.2.7.1 North America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.2.7.2 United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.2.7.2.1 United States: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.2.2 United States: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.2.3 United States: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.2.4 United States: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.7.3 Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.2.7.3.1 Canada: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.3.2 Canada: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.3.3 Canada: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.3.4 Canada: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.2.7.4 Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.2.7.4.1 Mexico: Antibody Drug Conjugates Market Breakdown, by Technology
11.2.7.4.2 Mexico: Antibody Drug Conjugates Market Breakdown, by Application
11.2.7.4.3 Mexico: Antibody Drug Conjugates Market Breakdown, by Target
11.2.7.4.4 Mexico: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Antibody Drug Conjugates Market Overview
11.3.2 Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3 Europe: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.3.1 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Technology
11.3.4 Europe: Antibody Drug Conjugates Market Breakdown, by Application
11.3.4.1 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Application
11.3.5 Europe: Antibody Drug Conjugates Market Breakdown, by Target
11.3.5.1 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Target
11.3.6 Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.6.1 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.7 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.3.7.1 Europe: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.3.7.2 United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.2.1 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.2.2 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.2.3 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.2.4 United Kingdom: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.3 Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.3.1 Germany: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.3.2 Germany: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.3.3 Germany: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.3.4 Germany: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.4 France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.4.1 France: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.4.2 France: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.4.3 France: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.4.4 France: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.5 Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.5.1 Italy: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.5.2 Italy: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.5.3 Italy: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.5.4 Italy: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.6 Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.6.1 Spain: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.6.2 Spain: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.6.3 Spain: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.6.4 Spain: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.3.7.7 Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Technology
11.3.7.7.2 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Application
11.3.7.7.3 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Target
11.3.7.7.4 Rest of Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Antibody Drug Conjugates Market Overview
11.4.2 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.3.1 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Technology
11.4.4 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Application
11.4.4.1 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Application
11.4.5 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Target
11.4.5.1 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Target
11.4.6 Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.6.1 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.7 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.4.7.1 Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.4.7.2 China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.2.1 China: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.2.2 China: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.2.3 China: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.2.4 China: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.3 Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.3.1 Japan: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.3.2 Japan: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.3.3 Japan: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.3.4 Japan: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.4 India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.4.1 India: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.4.2 India: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.4.3 India: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.4.4 India: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.5 Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.5.1 Australia: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.5.2 Australia: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.5.3 Australia: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.5.4 Australia: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.6 South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.6.1 South Korea: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.6.2 South Korea: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.6.3 South Korea: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.6.4 South Korea: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.4.7.7 Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Technology
11.4.7.7.2 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Application
11.4.7.7.3 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Target
11.4.7.7.4 Rest of APAC: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Antibody Drug Conjugates Market Overview
11.5.2 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.3.1 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Technology
11.5.4 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.4.1 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Application
11.5.5 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.5.1 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Target
11.5.6 Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.6.1 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.7 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.5.7.1 Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.5.7.2 South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.5.7.2.1 South Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.2.2 South Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.2.3 South Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.2.4 South Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.3 Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.5.7.3.1 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.3.2 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.3.3 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.3.4 Saudi Arabia: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.4 United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.4.2 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.4.3 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.4.4 United Arab Emirates: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.5.7.5 Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology
11.5.7.5.2 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application
11.5.7.5.3 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target
11.5.7.5.4 Rest of Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Antibody Drug Conjugates Market Overview
11.6.2 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.6.3 South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.3.1 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Technology
11.6.4 South and Central America: Antibody Drug Conjugates Market Breakdown, by Application
11.6.4.1 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Application
11.6.5 South and Central America: Antibody Drug Conjugates Market Breakdown, by Target
11.6.5.1 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Target
11.6.6 South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.6.1 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Distribution Channel
11.6.7 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.6.7.1 South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast Analysis – by Country
11.6.7.2 Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.6.7.2.1 Brazil: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.2.2 Brazil: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.2.3 Brazil: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.2.4 Brazil: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.7.3 Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.6.7.3.1 Argentina: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.3.2 Argentina: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.3.3 Argentina: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.3.4 Argentina: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
11.6.7.4 Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology
11.6.7.4.2 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Application
11.6.7.4.3 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Target
11.6.7.4.4 Rest of South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1.1 Heat Map Analysis
12.1.2 Company Share Analysis:
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Antibody Drug Conjugates Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 ADC Therapeutics SA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. Hoffmann-La Roche Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Daiichi Sankyo Co Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 SWOT Analysis
14.4.5 Key Developments
14.5 GSK Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 SWOT Analysis
14.5.5 Key Developments
14.6 Gilead Sciences Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca Plc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Astellas Pharma Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 RemeGen Co Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 SWOT Analysis
14.9.5 Key Developments
14.10 Takeda Pharmaceutical Co Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Merck KGaA
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Johnson & Johnson
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Bristol-Myers Squibb Co
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
14.14 BioNTech SE
14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments
14.15 AbbVie Inc
14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments
15. Appendix
15.1 About The Insight Partners
List of Tables
Table 1. Antibody Drug Conjugates Market Segmentation
Table 2. List of Vendors
Table 3. Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Table 4. Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 5. Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 6. Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million) – by Target
Table 7. Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 8. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 9. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 11. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 12. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 13. United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 14. United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 16. United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 17. Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 18. Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 19. Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 20. Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 21. Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 22. Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 23. Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 24. Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 25. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 26. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 27. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 28. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 29. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 30. United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 31. United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 32. United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 33. United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 34. Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 35. Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 36. Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 37. Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 38. France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 39. France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 41. France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 42. Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 43. Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 44. Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 45. Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 46. Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 47. Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 48. Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 49. Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 50. Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 51. Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 52. Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 53. Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 54. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 55. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 57. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 58. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 59. China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 60. China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 61. China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 62. China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 63. Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 64. Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 66. Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 67. India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 68. India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 70. India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 71. Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 72. Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 73. Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 74. Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 75. South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 76. South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 77. South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 78. South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 79. Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 80. Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 81. Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 82. Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 83. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 84. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 86. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 87. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 88. South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 89. South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 90. South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 91. South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 92. Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 93. Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 94. Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 95. Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 96. United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 97. United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 99. United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 100. Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 101. Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 102. Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 103. Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 104. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 105. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 106. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 107. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 108. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 109. Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 110. Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 111. Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 112. Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 113. Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 114. Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 115. Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 116. Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 117. Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Technology
Table 118. Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 119. Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Target
Table 120. Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel
Table 121. Company Share Analysis
Table 122. Recent Organic Growth Strategies in Antibody Drug Conjugates Market
Table 123. Recent Inorganic Growth Strategies in the Antibody Drug Conjugates Market
List of Figures
Figure 1. Antibody Drug Conjugates Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Antibody Drug Conjugates Market Revenue (US$ Million), 2021–2031
Figure 5. Antibody Drug Conjugates Market Share (%) – by Technology (2023 and 2031)
Figure 6. Cleavable Linker: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Non-cleavable Linker: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Antibody Drug Conjugates Market Share (%) – by Application (2023 and 2031)
Figure 9. Blood Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Brain Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Breast Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Ovarian Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lung Cancer: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Antibody Drug Conjugates Market Share (%) – by Target (2023 and 2031)
Figure 16. HER2: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. CD22: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. CD30: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Antibody Drug Conjugates Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 21. Retail Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Hospital Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Pharmacies: Antibody Drug Conjugates Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Antibody Drug Conjugates Market Breakdown by Region, 2023 and 2031 (%)
Figure 25. North America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. North America: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 27. North America: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 28. North America: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 29. North America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 30. North America: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. United States: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Canada: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Mexico: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 36. Europe: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 37. Europe: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 38. Europe: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 39. Europe: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. United Kingdom: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Germany: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. France: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Spain: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 48. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 49. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 50. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 51. Asia Pacific: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. China: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Japan: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. India: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Australia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. South Korea: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Rest of APAC: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 60. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 61. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 62. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 63. Middle East and Africa: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 64. South Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 65. Saudi Arabia: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 66. United Arab Emirates: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Rest of Middle East and Africa: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. South and Central America: Antibody Drug Conjugates Market Breakdown, by Technology (2023 and 2031)
Figure 70. South and Central America: Antibody Drug Conjugates Market Breakdown, by Application (2023 and 2031)
Figure 71. South and Central America: Antibody Drug Conjugates Market Breakdown, by Target (2023 and 2031)
Figure 72. South and Central America: Antibody Drug Conjugates Market Breakdown, by Distribution Channel (2023 and 2031)
Figure 73. South and Central America: Antibody Drug Conjugates Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 74. Brazil: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 75. Argentina: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 76. Rest of South and Central America: Antibody Drug Conjugates Market – Revenue and Forecast to 2031(US$ Million)
Figure 77. Growth Strategies in Antibody Drug Conjugates Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For